TABLE 5.
Performance with clinical specimens
| Target | Result | TORa pos | TOR neg | Overall agreement | PPAb (95% CI) | NPAc (95% CI) |
|---|---|---|---|---|---|---|
| AP | Fusion Pos | 49 | 0 | 98.8% (93.3%–99.8%) | 98.0% (89.5%–99.6%) | 100% (88.7%–100.0%) |
| Fusion Neg | 1 | 30 | ||||
| BM | Fusion Pos | 45 | 0 | 100% (95.1%–100.0%) | 100.0% (92.1%–100.0%) | 100% (88.7%–100.0%) |
| Fusion Neg | 0 | 30 | ||||
| EC | Fusion Pos | 30 | 0 | 100% (95.4%–100.0%) | 100% (88.7%–100.0%) | 100% (92.9%–100.0%) |
| Fusion Neg | 0 | 50 |
Test of record (TOR).
Positive Percent Agreement (PPA).
Negative Percent Agreement (NPA).